BioCentury
ARTICLE | Company News

Prelude, Rosetta Genomics deal

May 4, 2015 7:00 AM UTC

Rosetta Genomics acquired fellow molecular diagnostics and services company PersonalizeDx from Prelude for $2 million in cash and 500,000 Rosetta shares valued at $1.5 million based on Rosetta’s close...